05-611
抗磷酸化-VASP (Ser239) 抗体，克隆16C2
clone 16C2, Upstate®, from mouse
登录 查看组织和合同定价。
选择尺寸
关于此项目
UNSPSC Code:
12352203
NACRES:
NA.41
eCl@ss:
32160702
Clone:
16C2, monoclonal
Species reactivity:
mouse, rat, human
Application:
FACS, ICC, WB
Citations:
18
biological source
mouse
antibody form
purified immunoglobulin
antibody product type
primary antibodies
clone
16C2, monoclonal
species reactivity
mouse, rat, human
manufacturer/tradename
Upstate®
technique(s)
flow cytometry: suitable, immunocytochemistry: suitable, western blot: suitable
isotype
IgG1κ
NCBI accession no.
UniProt accession no.
shipped in
wet ice
target post-translational modification
phosphorylation (pSer239)
Quality Level
Gene Information
human ... VASP(7408)
General description
50kDa
Immunogen
磷酸化肽，对应于人磷酸化VASP（RKV[pS]KQE）的236-242位氨基酸
Application
研究子类别
细胞骨架信号转导
细胞骨架信号转导
研究类别
信号传导
信号传导
该抗磷酸化VASP (Ser239)抗体，克隆16C2经过验证可用在FC、WB、IC中，检测磷酸化VASP (Ser239)。
Biochem/physiol Actions
磷酸化VASP
基于序列同源性，预计该抗体也会与犬和牛发生交叉反应。
Physical form
100 µg来自无血清细胞培养上清液的小鼠IgG1，通过亲硫吸附和尺寸排阻色谱法纯化。 从1 ml PBS、0.1%叠氮化钠、PEG和蔗糖中冻干。 冻干粉末。用100 µL H2O复溶（15 min，RT），使最终浓度为1 mg/mL。 储存于 -20°C。
亲硫吸附色谱
形式：纯化
Preparation Note
在-20°C下可保存2年
Analysis Note
通过免疫印迹对CTLL细胞的RIPA裂解液进行了常规评估
Legal Information
UPSTATE is a registered trademark of Merck KGaA, Darmstadt, Germany
Disclaimer
除非我们的产品目录或产品附带的其他公司文档另有说明，否则我们的产品仅供研究使用，不得用于任何其他目的，包括但不限于未经授权的商业用途、体外诊断用途、离体或体内治疗用途或任何类型的消费或应用于人类或动物。
未找到合适的产品？
试试我们的产品选型工具.
存储类别
10 - Combustible liquids
I Kishimoto et al.
Journal of neuroendocrinology, 20(11), 1213-1223 (2008-08-30)
Cyclic GMP (cGMP) is known to play important roles for neuronal development and neurite pathfinding. However, the regulatory mechanism that governs the synthesis of cGMP in the nervous system is not well defined. In the present study, we examined the
Insulin stimulates glucose transport via nitric oxide/cyclic GMP pathway in human vascular smooth muscle cells.
Bergandi, L; Silvagno, F; Russo, I; Riganti, C; Anfossi, G; Aldieri, E; Ghigo, D; Trovati et al.
Arteriosclerosis, Thrombosis, and Vascular Biology null
A Mülsch et al.
Circulation, 103(17), 2188-2194 (2001-05-23)
Chronic in vivo treatment with nitroglycerin (NTG) induces tolerance to nitrates and cross-tolerance to nitrovasodilators and endothelium-derived nitric oxide (NO). We previously identified increased vascular superoxide formation and reduced NO bioavailability as one causal mechanism. It is still controversial whether
Jonel Trebicka et al.
Hepatology (Baltimore, Md.), 47(4), 1264-1276 (2008-03-06)
In cirrhosis, splanchnic vasodilation contributes to portal hypertension, subsequent renal sodium retention, and formation of ascites. Urotensin II(U-II) is a constrictor of large conductive vessels. Conversely, it relaxes mesenteric vessels, decreases glomerular filtration, and increases renal sodium retention. In patients
Olena Rudyk et al.
Circulation, 126(3), 287-295 (2012-06-12)
Although nitroglycerin has remained in clinical use since 1879, the mechanism by which it relaxes blood vessels to lower blood pressure remains incompletely understood. Nitroglycerin undergoes metabolism that generates several reaction products, including oxidants, and this bioactivation process is essential
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持